Half Year 2024 PolyPeptide Group AG Earnings Call Transcript
Key Points
- Solid progress in H1 with marked improvement in profitability and operating cash flow.
- Upgrade in 2024 guidance to high-single-digit revenue growth with a positive mid-single-digit EBITDA margin.
- Peptide market continues to accelerate, positioning PolyPeptide Group AG (XSWX:PPGN) as a key player.
- Target to double revenues by 2028 and expand EBITDA margin from -2% in 2023 to 25% by 2028.
- Operational excellence program driving improvements in manufacturing planning and execution, resulting in higher capacity utilization.
- Development business saw a decrease of EUR 3 million compared to 2023.
- Higher people costs driven by an 8.1% increase in headcount, impacting profitability.
- Significant investment in inventory ahead of planned growth in H2 2024, affecting cash flow.
- Ramp-up costs for new large-scale capacity in Braine impacting H2 2024 margins.
- Potential competition from new entrants in the peptide market, increasing market pressure.
Good morning, everybody. Thank you for joining our call. I'm joined in the room by Juan José Gonzalez, our CEO; and Marc Augustin, our CFO. They will run you through the presentation, and then they are open to take your questions at the end.
As usual, I draw your attention to the disclaimer on slide number 2. Sandra already told you about the usual procedure regarding the Q&A. You can ask it over the phone or in the chat function.
And with that, over to you, Juan José.
Thank you, Michael, and good morning, everyone. Thank you for joining us today. The objective for this session is to give you an update in terms of our operation and organizational progress. Then, Marc will walk you through over our H1 financial results, including the upgrade for our 2024 guidance. And then, we'll step back and share with you how we see the peptide market evolving, what is our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
